Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US
Tuesday, November 24, 2009 - 08:14
in Health & Medicine
Researchers from the University of Michigan determined that only 663,000 of the approximately 3.9 million Americans with hepatitis C virus (HCV) infection received antiviral therapy between 2002 and 2007. Treatment rates appear to be declining, in part because only half of the patients know they are infected.